Citation: Jm. Riedinger, POST-MARCOS POLITICS - A GEOGRAPHICAL AND STATISTICAL-ANALYSIS OF THE1992 PRESIDENTIAL-ELECTION - LANDE,CH, The American political science review, 92(3), 1998, pp. 732-732
Authors:
LIZARDNACOL S
COUDERT B
RIEDINGER JM
FARGEOT P
GUERRIN J
Citation: S. Lizardnacol et al., P53 GENE ALTERATIONS ARE ASSOCIATED WITH A DECREASED RESPONSIVENESS TO NEOADJUVANT CHEMOTHERAPY IN HUMAN BREAST-CANCER, International journal of oncology, 10(6), 1997, pp. 1203-1207
Authors:
LIZARDNACOL S
RIEDINGER JM
LIZARD G
GLASSER AL
COUDRAY N
CHAPLAIN G
GUERRIN J
Citation: S. Lizardnacol et al., LOSS OF HETEROZYGOSITY AT THE TP53 GENE - INDEPENDENT OCCURRENCE FROMGENETIC INSTABILITY EVENTS IN NODE-NEGATIVE BREAST-CANCER, International journal of cancer, 72(4), 1997, pp. 599-603
Authors:
RIEDINGER JM
COUDERT B
BARILLOT I
BUFFENOIR G
MAYER F
FARGEOT P
CUISENIER J
GUERRIN J
Citation: Jm. Riedinger et al., CLINICAL INTEREST OF ESTIMATION OF THE GROWTH-KINETICS OF OVARIAN PRIMARY RECURRENCES BY CA125 DOUBLING TIME, Bulletin du cancer, 84(9), 1997, pp. 855-860
Authors:
RIEDINGER JM
BARILLOT I
COUDERT B
FARGEOT P
BERRIOLORIEDINGER A
GUERRIN J
Citation: Jm. Riedinger et al., PROGNOSTIC-SIGNIFICANCE OF THE CA-125 INI TIAL HALF-LIFE MEASURED DURING FIRST-LINE CHEMOTHERAPY IN 62 PATIENTS WITH EPITHELIAL OVARIAN-CANCER STAGE-III OR STAGE-IV, Bulletin du cancer, 83(8), 1996, pp. 654-663
Authors:
COUDERT B
DEGISLAIN C
BELTRAMO JL
GUIGUES B
MAYER F
BRUCHON Y
RIEDINGER JM
FARGEOT P
DUMAS M
GUERRIN J
Citation: B. Coudert et al., THERAPEUTIC MONITORING OF 120 HOURS CONTI NUOUS 5-FLUOROURACIL ASSOCIATED WITH CISPLATIN, Bulletin du cancer, 83(10), 1996, pp. 847-852
Authors:
RIEDINGERBERRIOLO A
TOUZERY C
CHEVET D
TOUBEAU M
RIEDINGER JM
MEZERAY C
BRUNOTTE F
Citation: A. Riedingerberriolo et al., NORMAL RANGE OF [TC-99M]MAG-3 RENOGRAM PARAMETERS IN RENAL-TRANSPLANTRECIPIENTS, Transplantation proceedings, 26(1), 1994, pp. 301-302
Authors:
LIZARDNACOL S
ARNOULD L
RIEDINGER JM
ARNAL M
COLLIN F
GUERRIN J
Citation: S. Lizardnacol et al., AMPLIFICATION OF C-MYC AND C-ERB-BETA-2 ( HER-2 NEU) IN BREAST-CANCERWITHOUT LYMPH-NODE INVOLVEMENT - CORRELATION WITH OTHER PROGNOSTIC PARAMETERS/, Bulletin du cancer, 81(9), 1994, pp. 780-784